+427.0%
GE vs CVS
+14.2%
+412.8%
-43.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.4% | +0.6% | +0.9% | +1.3% |
| 7D | +4.0% | +12.0% | -7.9% | +2.1% |
| 30D | +11.1% | +2.8% | +8.3% | +10.2% |
| 3M | -6.7% | -3.6% | -3.2% | -6.5% |
| 6M | +14.3% | -1.6% | +15.9% | +13.8% |
| YTD | +11.7% | +16.3% | -4.5% | +7.2% |
| 1Y | +10.9% | +15.5% | -4.6% | +6.4% |
| 3Y | +279.0% | +48.1% | +230.9% | +238.9% |
| 5Y | +427.0% | +12.3% | +414.7% | +411.1% |
| All | +427.0% | +14.2% | +412.8% | +411.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling